We report a case of a collision tumour occurring in the right thyroid lobe. The collision tumour had lesions with features of MTC and PTC at two different locations that were separated by normal thyroid tissue. In addition, a separate focus of papillary carcinoma in the left thyroid lobe, C-cell hyperplasia with granulomatous inflammation in the right thyroid lobe and metastasis of the medullary component to the right neck lymph nodes were also seen. To the best of our knowledge, this is the first report of such a combination of features.
I NTRO D U C TIO N
Thyroid carcinomas are divided into two main groups based on their embryonic origin: parafollicular or medullary carcinomas (i.e. those that arise from the neuroectodermal derivation of the fourth branchial arch), and follicular and papillary carcinomas (i.e. those of foregut endodermal origin that arise from the base of the tongue). Papillary thyroid carcinoma (PTC) is the most common (75%-80%) histological type of thyroid cancer, (1) whereas medullary thyroid carcinoma (MTC) represents only 5%-8% of cases. (2) Tumours showing both features are rare (less than 1% of all thyroid malignancies), (3) and have different clinical presentation and biological behaviour. This rare phenomenon may be observed in two settings -a mixed tumour showing dual differentiation (4) or a collision tumour (i.e. a tumour with two separate and different components). (5) To date, less than 40 cases of mixed medullary-papillary carcinoma have been reported in the literature.
We report a case of a collision tumour occurring in the right thyroid lobe. The collision tumour had lesions with features of MTC and PTC at two different locations that were separated by normal thyroid tissue. In addition, a separate focus of papillary carcinoma in the left thyroid lobe, C-cell hyperplasia with granulomatous inflammation in the right thyroid lobe and metastasis of the medullary component to the right neck lymph nodes were also seen. To the best of our knowledge, this is the first report of such a combination of features. Simultaneous medullary carcinoma, papillary carcinoma and granulomatous inflammation of the thyroid
CA S E R E PO RT

C a s e R e p o r t e147
The patient underwent total thyroidectomy with modified right and central cervical nodal clearance. Grossly, the right and left thyroid lobes each had a solid greyish-white nodule measuring 1 cm and 1.5 cm, respectively. Microscopic examination of the paraffin-embedded sections of the left thyroid nodule showed that it was a follicular variant of papillary carcinoma (Fig. 1b) . Another focus of papillary carcinoma, also a follicular variant, was seen microscopically in the right thyroid lobe; this focus was not identified during gross examination. The medullary carcinoma (Fig. 2a) , seen in the nodule of the right thyroid lobe, was immunopositive for calcitonin (Fig. 2b) , chromogranin, synaptophysin and carcinoembryonic antigen, and immunonegative for thyroglobulin. C-cell hyperplasia ( 
D I SCU S S IO N
Mixed medullary-papillary carcinomas are very rare. Most reports of thyroid carcinomas are of either the medullary or papillary type. Mixed medullary-papillary carcinomas were first described in the early 1980s; (6) Lax et al (7) reported three cases in 1994, while Papotti et al (8) described an important series of 11 cases of mixed medullary-follicular cell thyroid carcinomas in 1997. In MTCs, which account for about 5%-8% of all thyroid carcinomas, (2) 3%-5% of the cases may display mixed features, with either a follicular or papillary component in the primary tumour, metastases, or both. 
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of thyroglobulin and calcitonin in the tumour cells. (9, 10) Another possible hypothesis is that a common oncogenic stimulus leads to the simultaneous transformation of both follicular and C-cell progenitor stem cells, and thus the formation of both medullary and follicular compounds.
Burstein et al (12) and Preto et al (13) suggested that the multipotentiality of main cells in a solid nest may be responsible for the histogenesis of C-cells, follicular cells, and also, thyroid tumours. Volante et al, (14) 
A precise diagnosis of this uncommon variety of mixed thyroid carcinoma is crucial for both adequate patient treatment and genetic screening to exclude MEN2 syndrome and familial MTC. 
